A Role for Fetal Hemoglobin and Maternal Immune IgG in Infant Resistance to Plasmodium falciparum Malaria by Amaratunga, Chanaki et al.
A Role for Fetal Hemoglobin and Maternal Immune IgG
in Infant Resistance to Plasmodium falciparum Malaria
Chanaki Amaratunga
1, Tatiana M. Lopera-Mesa
1, Nathaniel J. Brittain
1, Rushina Cholera
1, Takayuki
Arie
2, Hisashi Fujioka
3, Jeffrey R. Keefer
4, Rick M. Fairhurst
1*
1Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of
America, 2Department of Physics and Electronics, School of Engineering, Osaka Prefecture University, Osaka, Japan, 3Department of Pharmacology, Case Western
Reserve University, Cleveland, Ohio, United States of America, 4Division of Pediatric Hematology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore,
Maryland, United States of America
Abstract
Background: In Africa, infant susceptibility to Plasmodium falciparum malaria increases substantially as fetal hemoglobin
(HbF) and maternal immune IgG disappear from circulation. During the first few months of life, however, resistance to
malaria is evidenced by extremely low parasitemias, the absence of fever, and the almost complete lack of severe disease.
This resistance has previously been attributed in part to poor parasite growth in HbF-containing red blood cells (RBCs). A
specific role for maternal immune IgG in infant resistance to malaria has been hypothesized but not yet identified.
Methods and Findings: We found that P. falciparum parasites invade and develop normally in fetal (cord blood, CB) RBCs,
which contain up to 95% HbF. However, these parasitized CB RBCs are impaired in their binding to human microvascular
endothelial cells (MVECs), monocytes, and nonparasitized RBCs – cytoadherence interactions that have been implicated in
the development of high parasite densities and the symptoms of malaria. Abnormal display of the parasite’s cytoadherence
antigen P. falciparum erythrocyte membrane protein-1 (PfEMP-1) on CB RBCs accounts for these findings and is reminiscent
of that on HbC and HbS RBCs. IgG purified from the plasma of immune Malian adults almost completely abolishes the
adherence of parasitized CB RBCs to MVECs.
Conclusions: Our data suggest a model of malaria protection in which HbF and maternal IgG act cooperatively to impair the
cytoadherence of parasitized RBCs in the first few months of life. In highly malarious areas of Africa, an infant’s
contemporaneous expression of HbC or HbS and development of an immune IgG repertoire may effectively reconstitute
the waning protective effects of HbF and maternal immune IgG, thereby extending the malaria resistance of infancy into
early childhood.
Citation: Amaratunga C, Lopera-Mesa TM, Brittain NJ, Cholera R, Arie T, et al. (2011) A Role for Fetal Hemoglobin and Maternal Immune IgG in Infant Resistance
to Plasmodium falciparum Malaria. PLoS ONE 6(4): e14798. doi:10.1371/journal.pone.0014798
Editor: Anne Charlotte Gruner, Agency for Science, Technology and Research (A*STAR), Singapore
Received November 5, 2009; Accepted January 25, 2011; Published April 12, 2011
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious
Diseases. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rfairhurst@niaid.nih.gov
Introduction
In Africa, resistance to Plasmodium falciparum malaria in the first
few months of life is evidenced by extremely low parasitemias, the
absence of fever, and the almost complete lack of severe disease
[1]. Infant susceptibility to malaria then increases substantially as
fetal hemoglobin (HbF) and maternal immune IgG disappear from
circulation. Fetal red blood cells (RBCs), which contain HbF
(a2c2), have higher affinity for oxygen than adult RBCs, which
contain hemoglobin A (HbA; a2b2), and this facilitates transfer of
oxygen from the maternal to the fetal circulation. The switch from
production of c to b globin begins in utero and results in the linear
decline of HbF in the fetal RBC population, such that HbF levels
of 50–95% at birth decline to ,5% by three months [2]. Levels of
maternal IgG, which protect the mother from high-density
parasitemia and malaria symptoms, are similar in maternal and
cord blood at birth [3], and can be expected to also decline
markedly in infants during this time period.
Infantresistancetomalariahaspreviouslybeenattributed topoor
parasite growth in HbF-containing RBCs. While several studies
have established that P. falciparum parasites readily invade cord
blood (CB) RBCs [4,5,6], the presence of HbF in three RBC types
(CB, infant, and adult hereditary persistence of fetal hemoglobin,
HPFH) was believed to restrict parasite growth [4,5,6,7]. Biochem-
ical explanations for these findings were provided by studies that
concluded that the ability of HbF-containing RBCs to handle the
oxidative stress imposed by developing parasites is impaired [7], or
thatHbFisinefficientlydigestedbyP.falciparumhemoglobinases[8].
While malaria resistance in infants has also been attributed to IgG
acquired from immune mothers, support for this hypothesis is
lacking. For example, most studies have failed to detect positive
correlations between levels of parasite-specific maternal antibodies
and measures of disease susceptibility in infants, including time to
first parasite infection, density of parasites in the blood, and
incidence of febrile episodes [9].
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immunity, we sought to identify the mechanisms that confer such
high levels of malaria resistance to infants. Our findings that P.
falciparum parasites invade and develop normally in HbF-
containing RBCs suggested an alternative mechanism of malaria
resistance by HbF. We found that HbF impairs the binding of
parasitized RBCs to human microvascular endothelial cells
(MVECs), monocytes, and nonparasitized erythrocytes – cytoad-
herence interactions that contribute to the development of high
parasite densities and the symptoms of malaria. Abnormal display
of the parasite’s cytoadherence antigen P. falciparum erythrocyte
membrane protein-1 (PfEMP-1) on HbF RBCs correlates with
these findings and is similar to that on HbC and HbS RBCs
[10,11]. We also found that IgG purified from the plasma of
immune Malian adults markedly reduces the adherence of
parasitized CB RBCs to MVECs. Taken together, these data
suggest a model of malaria protection in which HbF and maternal
PfEMP-1-specific IgG act cooperatively to impair the cytoadher-
ence of parasitized RBCs in the first few months of life. HbS and
HbC may thus have been naturally selected for their ability to
reconstitute the waning protective effects of HbF in highly
malarious areas of Africa, where IgG repertoires specific for
PfEMP-1 variants are rapidly acquired.
Methods
Ethics Statement
Blood collections were approved by the Institutional Review
Boards of the National Institute of Allergy and Infectious Diseases,
the National Heart, Lung and Blood Institute, the Johns Hopkins
School of Medicine, and the Ethics Committee of the Faculty of
Medicine, Pharmacy, and Odontostomatology at the University of
Bamako. All volunteers gave written informed consent.
Erythrocytes
Adult HbA-containing (AA) and CB RBC samples were drawn
into VacutainersH containing acid-citrate-dextrose anticoagulant.
CB samples were obtained from term deliveries and CB
hemolysates contained 79%–100% HbF. After removing buffy
coat leukocytes, RBCs were washed three times with RPMI-1640
(Invitrogen, Carlsbad, CA) and stored at 50% hematocrit at 4uC
prior to use (within 4–36 h of blood draw). Hemoglobin types were
determined by HPLC (D-10 Instrument, Bio-Rad, Hercules, CA).
In all experiments, AA and CB (or HPFH) RBCs were
simultaneously obtained and processed in parallel. The HPFH
RBCs (containing 100% HbF) were obtained from a single adult
donor.
Parasite culture
P. falciparum lines (3D7, 7G8, FVO, GB4, MC/R+, TM284,
FCR-3, A4tres) were cultured in O+ RBCs at 5% hematocrit in
complete medium (CM; RPMI-1640 supplemented with 25 mg/
mL HEPES, 2 mg/mL sodium bicarbonate, 50 mg/mL gentami-
cin, and either 10% heat-inactivated human AB+ serum or 0.5%
Albumax II (Gibco-BRL, Grand Island, NY)). Knobby parasite
lines were maintained by periodic gelatin flotation. Cultures were
maintained at 37uC in a humidified atmosphere of 5% CO2 in air
and media were changed every 8–24 h. Trophozoite-infected
RBCs containing paramagnetic hemozoin were enriched to
.95% purity by magnetic separation (Miltenyi Biotec, Auburn,
CA), inoculated into AA and CB (or HPFH) RBC samples, and
cultured at 1–2% hematocrit as above. In all experiments,
parasitized RBCs were assayed after a single cycle of invasion to
the ring stage (,18 h) or development to the trophozoite stage
(,40 h). To avoid the confounding effects of in vitro RBC
senescence on parasite invasion and development, we did not
monitor parasite growth in subsequent cycles.
Invasion and development assays
Mature parasitized RBCs were inoculated into 5 mL CM
containing 5610
8 AA or CB erythrocytes. The numbers of ring
parasitized RBCs per 1000 RBCs were counted at 18 h. Five P.
falciparum lines (7G8, FVO, GB4, MC/R+, TM284) were tested in
4 AA and 6 CB RBC samples. At ,40 h, mature parasitized
RBCs were stained with ethidium bromide (2 mg/mL) at room
temperature for 30 min and quantified by flow cytometry.
Endothelial cell adherence assay
Adult dermal human microvascular endothelial cells (MVECs;
Cambrex Biosciences, Walkersville, MD) were maintained in the
manufacturer’s EGM2-MV medium and grown on LabTek CC-2
coated 8-well chamber slides (Nalge Nunc International, Roches-
ter, NY) to ,50% confluency at 37uC in a humidified atmosphere
of 5% CO2. Mature parasitized RBCs were adjusted to 5–20%
parasitemia and 0.5–1% hematocrit by the addition of nonpar-
asitized RBCs in binding media (BM; RPMI-1640, 0.5% BSA,
pH 6.7). Adherent endothelial cells were washed with BM and
then incubated with 150 mL of the parasitized RBC suspension for
1 h at ambient temperature with constant orbital agitation
(100 rpm). In some experiments, these incubations were carried
out in the presence of various concentrations of purified non-
immune and immune IgG. After parasite suspensions were
removed from each well, slides were washed by dipping 4 times
in BM at 37uC, fixed in 2% glutaraldehyde at ambient
temperature for 2 h, and stained in 10% Giemsa for 60 min. In
each experiment, the number of parasitized RBCs bound to ,700
endothelial cells was counted from duplicate wells. These counts
were then expressed as the number of parasitized RBCs bound to
100 MVECs.
Purification of IgG from human plasma
Serum was obtained from non-immune or immune individuals
(i.e., Malian adults with ‘disease-controlling immunity’). IgG was
purified from pooled serum samples by Protein G PLUS gel
(Pierce, Rockford, IL) according to the manufacturer’s directions.
Eluted IgG was dialyzed in RPMI-1640, concentrated to
approximately 80 mg/mL, and sterilized with a 0.22 mm filter
(Millipore, Billerica, MA). Purified IgG was pre-adsorbed with
human A positive and B positive RBCs (25 mL of packed
erythrocytes per 1 mL of sample) and then stored at 4uC for
immediate use or at 280uC. IgG was used in cytoadherence assays
at final concentrations of 0.5–10 mg/mL.
Monocyte adherence assay
CD14+ monocytes (Cambrex Biosciences) were plated onto
CC2 Lab-Tek chamber slides (Nalge Nunc International) at
4610
5 cells per well and cultured for 48 h in RPMI 1640
containing 25 mM HEPES, 50 mg/mL gentamicin, and 10% fetal
bovine serum at 37uC in an atmosphere of 5% CO2. AA and CB
RBCs infected with P. falciparum trophozoites (3D7, A4tres, FCR-
3) were purified by magnetic separation, adjusted to 10–15%
parasitemia and 1% hematocrit as previously described. Adherent
monocytes were washed with binding media and incubated with
150 mL of the parasitized RBC suspension for 1 h at ambient
temperature with gentle orbital agitation. The parasite suspension
was removed from each well and the slides were gently washed by
dipping four times in binding media. Slides were dried and stained
Fetal Hemoglobin and Malaria
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counting the number of parasitized RBCs bound to a minimum of
700 monocytes from duplicate wells. These counts were then
expressed as the number of parasitized RBCs bound to 100
monocytes.
Rosetting
MC/R
+ and TM284 parasites were cultured in AA and CB
RBCs as above to 5% to 10% parasitemia. RBCs containing
mature parasites were identified by their refractive hemozoin
pigment. Rosettes were identified as parasitized RBCs to which
three or more nonparasitized RBCs closely adhered. The rosette
frequency was determined by dividing the total number of rosettes
by .200 parasitized RBCs examined.
Flow cytometry
Rat or rabbit polyclonal antisera raised against PfEMP-1
variants expressed by the P. falciparum lines FVO, MC/R+, and
A4tres were kindly provided by Morris Makobongo and Dror
Baruch (Malaria Vaccine Development Branch, NIAID). Samples
of RBCs containing synchronized trophozoites (1.5610
6 cells; 1%
parasitemia) were stained with various dilutions of antiserum in
FACS staining buffer (FSB; PBS, 2% FBS, 0.1% sodium azide) for
45 min at room temperature and washed twice with FSB. Samples
were then incubated with Alexa 488-conjugated anti-rat or anti-
rabbit IgG (Molecular Probes, Inc., Eugene, OR) and ethidium
bromide (2 mg/mL) at room temperature for 30 min and washed
twice with FSB. A FACSort instrument (Becton-Dickinson, San
Jose, CA) and FlowJo software (Tree Star, Inc., Ashland, OR)
were used to acquire and analyze 250,000 to 500,000 events from
each sample.
Surface immunofluorescence/confocal microscopy
Parasitized RBCs (5 ml packed cell volume) were added to 50 ml
rat polyclonal antiserum (1:10 dilution, MC/R+; 1:500 dilution,
FVO) for 1 h at ambient temperature and washed. Bound
antibody was detected with Alexa 488-conjugated anti-rat IgG
(Molecular Probes, Inc.). Images were collected using a TCS-SP2
AOBS confocal microscope (Leica Microsystems, Wetzlar, Ger-
many) using a 63X oil immersion objective NA 1.4, zoom 6. The
confocal pinhole was set to 0.9 Airy units to ensure maximum
resolution. Alexa 488 fluorescence was excited using an argon laser
at 488 nm. 3-dimensional reconstructions were made using
sequential sections through the sample with a z increment of
0.12 mm. Images were deconvoluted and processed using Leica
TCS (version 2.1374), Imaris 4.1 (3-D reconstructions) (Bitplane
AG), Huygens Essentials (deconvolution) (SVI) and Adobe Photo-
shop CS (Adobe Systems).
Atomic force microscopy
Samples of parasitized RBCs for atomic force microscopy
(AFM) imaging were prepared as described [11,12]. A Bioscope
AFM (Veeco Instruments, Santa Barbara, CA) on a wide-field
Axiovert 200 fluorescence microscope (Carl Zeiss, Inc., Thorn-
wood, NY) was optimized to image the surface topography of
RBCs and to identify the parasite stage within an individual AFM-
imaged RBC. The X and Y piezoelectric scanners of the Bioscope
AFM were disconnected. A custom built closed-loop XY scanner
stage (nPoint, Inc., Madison, WI) was used to minimize scanning
artifacts and thermal drift of the scanner for improved image
accuracy. AFM was performed in tapping mode in air using
Nanosensors pointprobe tips (Nanosensors, Switzerland) with a
cantilever resonance frequency of 327–397 kHz. Topographic and
error signal (amplitude) images were collected simultaneously.
Parasites were stained with YOYO-1 fluorescent nucleic acid
staining reagent (Molecular Probes, Inc.). Bright field and
fluorescent images were collected with a chilled CCD video
camera (Model C5985, Hamamatsu Photonic Systems, Bridge-
water, NJ). Image-Pro Plus version 5.0 (Media Cybernetics, Silver
Spring, MD) was used to merge these images to allow the
unambiguous identification of the parasite stage.
Transmission electron microscopy
Parasitized RBCs were processed as described [13]. Briefly,
samples were fixed with 2.5% glutaraldehyde in 0.05 M phosphate
buffer, pH 7.4 containing 4% sucrose for 2 h and then postfixed in
1% osmium tetroxide for 1 h. After a 30-min en bloc stain with 1%
aqueous uranyl acetate, the cells were dehydrated in ascending
concentrations of ethanol and embedded in Epon 812. Ultrathin
sections were stained with 2% uranyl acetate in 50% methanol
and lead citrate and then examined in a Zeiss CEM902 electron
microscope (Oberkochen, Germany).
Statistical analysis
In assays of invasion, development, cytoadherence, and
rosetting, results from parasitized AA and CB (or HPFH) RBCs
were compared using the non-parametric Mann-Whitney test
(GraphPad Software, San Diego, CA). PfEMP-1 levels on the
surface of parasitized AA and CB erythrocytes were compared
using the paired t test. In all comparisons, 2-tailed P values were
calculated.
Results
P. falciparum parasites invade and develop normally in
HbF-containing RBCs
To investigate how HbF might impair parasite multiplication,
we examined the invasion and development of five P. falciparum
lines in AA and CB RBCs. Approximately 18 hours after
infection, the number of ring-infected RBCs per 1000 RBCs
(counted by light microscopy) did not differ significantly between
AA and CB RBCs (median (range); 20 (7–86) for AA samples vs. 22
(4–61) for CB samples, P=0.68, N=30) (Fig. 1a, Table S1).
Approximately 24 hours later, the number of trophozoite-infected
RBCs per 1000 RBCs (quantified by flow cytometry) did not differ
significantly between CB and AA RBCs (median (range); 16 (5–77)
for AA samples vs. 18 (5–46) for CB samples; P=0.69, N=23)
(Fig. 1b, Table S1). We observed neither morphological
abnormalities nor growth restriction as ring forms matured into
trophozoites and schizonts, even in RBCs containing 100% HbF
from an adult with HPFH (Figs. 1c, d). Using transmission
electron microscopy, we found that .99% of 480 trophozoite-
infected CB RBCs appeared viable (i.e., there was neither nuclear
condensation nor loss of membranous organelle integrity) (not
shown). These data indicate that HbF-containing RBCs support
robust invasion and development of P. falciparum.
HbF impairs the cytoadherence of P. falciparum-infected
RBCs
P. falciparum expresses PfEMP-1 cytoadherence proteins and
concentrates them in knob-like protrusions on the RBC surface,
where they mediate binding to a variety of host cells. The
sequestration of parasitized RBCs in microvessels (i.e., ‘sequestra-
tion’) is associated with life-threatening manifestations of malaria,
including the clinical syndrome of cerebral malaria [14,15,16,17].
Sequestration is believed to contribute to high parasite densities by
Fetal Hemoglobin and Malaria
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clearancefromthe bloodstreambythespleen[18].Theimportance
of sequestration to parasite survival is suggested by animal studies in
which the spleen modulates the in vivo sequestration and in vitro
cytoadherence properties of P. falciparum-infected RBCs [19,20],
and by studies showing that mature parasitized RBCs are efficiently
removed by ex vivo-perfused human spleens [21]. Sequestration not
only contributes to the development of high parasite densities but
also leads to microvascular inflammation and endothelial dysfunc-
tion [22,23,24].
Because sequestration is linked to parasite multiplication and
microvascular inflammation, we tested P. falciparum-infected RBCs
for their adherence to MVECs, which express the major host
adherence receptor CD36. Relative to parasitized AA RBCs,
parasitized CB RBCs showed an 82% reduction in adherence to
MVECs (median (range) number of parasitized RBCs per 100
MVECs; 205 (21–1657) for AA samples vs. 37 (0.1–614) for CB
samples, P=0.0013, N=24) (Figs. 2a, b, Table S1). Parasitized
HPFH RBCs (containing 100% HbF) showed a 88% reduction in
adherence to MVECs (median (range); 100 (19–1228) for AA
samples vs. 12 (0.4–13) for HPFH samples, P=0.10, N=3)
(Fig. 2a). These data suggest that HbF may reduce parasite
multiplication rates and dampen microvascular inflammation in
vivo by weakening the adherence of parasitized RBCs to MVECs.
The interaction between PfEMP-1 on parasitized RBCs and
CD36 on monocytes leads to monocyte activation and monokine
production in vitro [25,26,27]. Monocyte activation during P.
falciparum infection is believed to produce elevated levels of TNF
and other monokines implicated in the pathogenesis of malaria
[28]. To explore whether HbF might impair monocyte activation,
we tested the effect of HbF on the adherence of parasitized RBCs
to monocytes. We found that parasitized CB RBCs showed a 28%
reduction in adherence to monocytes relative to parasitized AA
RBCs (median (range) number of parasitized RBCs per 100
monocytes; 180 (78–188) for AA samples vs. 129 (17–148) for CB
samples, P=0.200, N=7) (Fig. 2c, Table S1). The level of
reduced adhesion of parasitized CB RBCs to monocytes is less
than that to MVECs. This is probably due to the higher levels of
CD36 on monocytes compared to MVECs (unpublished data).
These data suggest that HbF may weaken the interaction between
parasite RBCs and blood monocytes in vivo.
Rosette formation, the attachment of nonparasitized RBCs to
parasitized RBCs, is also PfEMP-1-mediated and is associated with
malaria severity in Africa [29,30]. Rosettes are proposed to
impede microvascular blood flow and to contribute to local
hypoxia-induced inflammation. In Saimiri monkeys, rosettes have
also been associated with elevated parasite multiplication rates in
vivo [31]. In this setting, rosette formation may enable short-lived
merozoites to efficiently recognize and invade suitable host RBCs
upon schizont rupture. To test how HbF affects this pathogenetic
interaction, we infected RBCs with rosetting P. falciparum lines and
cultured them for ,40 hours to allow for maturation to the
trophozoite stage, which expresses PfEMP-1. We then determined
the proportion of 200 parasitized RBCs that bound three or more
nonparasitized RBCs (i.e., rosette frequency) and found that
rosette frequencies were 25% lower in parasitized CB RBCs than
Figure 1. Invasion and development of P. falciparum in RBCs containing HbF. a, P. falciparum invasion of RBCs. The numbers of ring-infected
RBCs per 1000 AA or CB RBCs are shown. Median values are indicated by horizontal bars. b, P. falciparum development in RBCs. The numbers of
trophozoite-infected RBCs per 1000 AA or CB RBCs are shown. Median values are indicated by horizontal bars. Results in a and b were obtained from
5 parasite lines (7G8, GB4, MC/R+, FVO, TM284) and multiple blood donors (4AA, 6CB) (not all combinations tested). c, d, The photomicrographs show
mature parasites in AA (c) and HPFH (d) RBCs (containing 100% HbF) that are morphologically normal and synchronously developed.
doi:10.1371/journal.pone.0014798.g001
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(45%–60%) for AA samples vs. 39% (4%–47%) for CB samples,
P=0.0003, N=12) (Fig. 2d, Table S1). These data suggest that
HbF impairs rosetting, which may reduce parasite multiplication
rate and the degree of microvascular obstruction in vivo.
Abnormal PfEMP-1 and knob display on the surface of
P. falciparum-infected RBCs
Reduced expression of PfEMP-1 on the surface of parasitized
RBCs containing the malaria-protective HbC or HbS mutations is
associated with impaired cytoadherence [10,11]. Using specific
antisera in a flow cytometry assay, we found that parasitized CB
RBCs had a 40% reduction in surface PfEMP-1 levels relative to
parasitized AA RBCs (mean 6 SEM; 1111693 for AA samples vs.
674656 for CB samples, P,0.0001, N=48) (Fig. 2e, Table S1).
We were unable to detect PfEMP-1 on the surface of parasitized
HPFH RBCs containing 100% HbF (Fig. 2f). We also used an
immunofluorescence assay (IFA) to detect PfEMP-1 on the surface
of parasitized CB RBCs. By confocal microscopy, we found that
parasitized AA RBCs had a relatively homogeneous distribution of
PfEMP-1 (Fig. 3a). Signals from parasitized CB RBCs, however,
were heterogeneous, with some cells showing AA-like patterns
(Fig. 3b) and others showing dim and uneven patterns (Fig. 3c)
reminiscent of HbC and HbS RBCs [10,11].
PfEMP-1 molecules are concentrated on knob-like protrusions
that mediate contact between parasitized RBCs and MVECs or
Figure 2. Cytoadherence and surface PfEMP-1 levels of parasitized RBCs containing HbF. a, Adherence of parasitized RBCs to MVECs. The
numbers of parasitized AA, CB, and HPFH RBCs adhering to 100 MVECs are shown. Median values are indicated by horizontal bars. Results were
obtained from 4 parasite lines (3D7, 7G8, A4tres, FCR-3), multiple blood donors (7AA, 10CB, 1HPFH), and 5 endothelial cell lots (not all combinations
tested). b, The photomicrograph shows the adherence of parasitized AA RBCs to MVECs. c, Adherence of parasitized RBCs to blood monocytes. The
numbers of parasitized AA and CB RBCs adhering to 100 monocytes are shown. Median values are indicated by horizontal bars. Results were obtained
from 3 parasite lines (3D7, A4tres, FCR-3), multiple blood donors (4AA, 7CB), and 4 monocyte donors (not all combinations tested). d, Rosette
frequencies of parasitized RBCs. Median values are indicated by horizontal bars. Results were obtained from 2 parasite lines (MC/R+, TM284) and
multiple blood donors (4AA, 7CB) (not all combinations tested). e, PfEMP-1 expression levels (median fluorescence intensities, MFI) on the surface of
parasitized RBCs. Mean values are indicated by horizontal bars. Results were obtained from 2 parasite lines (MC/R+, FVO), multiple blood donors (4AA,
7CB), and various concentrations of 2 antisera. f, Flow cytometry analysis of PfEMP-1 expression on AA (left panel) and HPFH (right panel) RBCs
infected with the FVO P. falciparum line. Parasitized RBCs reactive to PfEMP-1-specific antiserum appear as a clustered population in the upper right
quadrant (left panel).
doi:10.1371/journal.pone.0014798.g002
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knobs, alterations in knob assembly can affect the amount and
distribution of PfEMP-1 [10,11,32]. To determine whether HbF is
associated with aberrant knob morphology and distribution, we
examined the surface of parasitized CB RBCs. Atomic force
micrographs showed populations of parasitized CB RBCs
expressing fine, regularly distributed knobs (Fig. 3d) characteristic
of parasitized AA RBCs, and populations expressing large, widely
separated knobs (Fig. 3e) reminiscent of HbC and HbS RBCs
[11,12]. The concordant appearance of these knob distributions
with the patterns of IFA signals (Figs. 3b, c) is consistent with
widely dispersed anchoring and irregular concentrations of
PfEMP-1 at the surface of parasitized CB RBCs. Transmission
electron micrographs of parasitized CB RBCs confirmed the
presence of normal (Fig. 3f) and abnormal (Fig. 3g) knob
morphologies. Knobs were found to be abnormal or entirely
absent on the surface of parasitized HPFH RBCs (Figure S1).
Immune IgG impairs the cytoadherence of
P. falciparum-infected RBCs
‘Disease-controlling immunity,’ which eventually develops in
adults residing permanently in malaria-endemic areas of Africa,
enables individuals to tolerate P. falciparum parasitemias without
developing the symptoms of malaria. Since disease-controlling
immunity to malaria is associated with the development of
PfEMP-1-specific antibodies [33], we hypothesized that PfEMP-
1-specific IgG works cooperatively with HbF to impair cytoad-
herence in vivo. To explore this possibility, we purified IgG from
pooled plasma obtained from adult residents of a malaria-endemic
area of Mali. The preparations of immune IgG agglutinated
parasitized RBCs (not shown), indicating that they recognized
PfEMP-1 (and perhaps other proteins) expressed on the surface of
these cells. Relative to non-immune IgG, immune IgG (at
physiologically-relevant levels of 10 mg/mL) essentially abrogated
the binding of parasitized AA and CB RBCs to MVECs (median
(range) number of parasitized RBCs per 100 MVECs; 472.5 (334–
712) vs. 13 (9–23) for AA samples, P=0.029, N=4; 242 (129–378)
vs. 9.5 (6–19) for CB samples, P=0.029, N=4)(Fig. 4a, Table
S2). To mimic the waning concentrations of maternal IgG in the
infant circulation, we also performed cytoadherence assays in the
presence of 0.5–6 mg/mL immune IgG. Relative to non-immune
IgG, immune IgG (at 0.5–6 mg/mL) reduced the binding of
parasitized AA and CB RBCs to MVECs (median (range) number
of parasitized RBCs per 100 MVECs; 169.5 (105–448) vs. 106 (59–
189) for AA samples, P=0.18, N=6; 79.5 (43–218) vs. 31.5 (8–65)
for CB samples, P=0.04, N=6)(Fig. 4a, Table S2). These data
indicate that lower concentrations (,10 mg/mL) of immune IgG
are able to effect greater reductions in the cytoadherence of
parasitized CB RBCs than parasitized AA RBCs, suggesting that
PfEMP-1-specific IgG works cooperatively with HbF to reduce
cytoadherence in vivo.
Discussion
Infant resistance to malaria has been associated temporally with
the presence of HbF-containing RBCs and transplacentally-
acquired, maternal immune IgG in the circulation. To date, the
mechanisms by which these two host factors might produce such
dramatic reductions in parasite density and malaria incidence have
not been established. In considering candidate mechanisms of
malaria resistance by HbF and immune IgG, we reasoned that
they should be consistent with two well-documented in vivo
observations. First, infant RBCs are inherently able to support the
invasion and development of P. falciparum, as evidenced by patent
parasitemias (up to 10,000/mL) in the first few months of life [9].
Second, passive transfer studies conducted 50 years ago showed
that immune IgG – but not nonimmune IgG – could rapidly drive
down parasitemias in African children with malaria [34]. While
invasion-inhibitory antibodies may contribute to this phenome-
non, the large and rapid decreases in parasitemias suggest a
Figure 3. Distributions of PfEMP-1 signals and knobs on the surface of parasitized AA and CB RBCs. a–c, Confocal cross-sections
through the mid-plane (left column) or maximum intensity projections of z stacks through the upper cell surface (right column) of trophozoite-
infected RBCs probed with a polyclonal antiserum against PfEMP-1 (FVO line). a, PfEMP-1 fluorescence patterns typical of a parasitized AA RBC. b,
Fluorescence patterns from a parasitized CB RBC, similar to those of parasitized AA RBCs. c, Irregular, patchy PfEMP-1 distribution on a parasitized CB
RBC. d,e, Atomic force micrographs of CB RBCs infected with the FVO P. falciparum line, showing normal AA-like (d) or abnormal (e) knob
appearances. The mean (6 SEM) width of 15 randomly selected knobs in panels d and e were 50.3 nm (63.4 nm) and 96.4 nm (66.7 nm),
respectively. Scale bar =1 mm. Transmission electron micrographs of CB RBCs infected with the FVO P. falciparum line also showed populations with
normal (f) or abnormal (g) knob appearances. Comparison atomic force and transmission electron micrographs of parasitized HbC and HbS RBCs can
be found in references 9, 10, and 11. Arrows indicate examples of normal (f) and abnormal (g) knobs.
doi:10.1371/journal.pone.0014798.g003
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PfEMP-1, such IgGs may prevent ring-parasitized RBCs from
sequestering and promote their efficient removal from the
circulation by the spleen. Accordingly, we hypothesized that
HbF and PfEMP-1-specific IgG work cooperatively in infants to
impair the cytoadherence of parasitized RBCs and prevent
sequestration, thus limiting the ability of P. falciparum to multiply
and cause inflammation.
In testing this hypothesis, we found that P. falciparum parasites
invade and develop normally in CB and HPFH RBCs, which
contain up to 100% HbF. This suggested that the presence of HbF
does not restrict parasite multiplication in vivo by killing
intraerythrocytic parasites. To explain how infants maintain
extremely low parasitemias (often detectable only by PCR
methods) and remain asymptomatic with relatively higher
parasitemias (up to 10,000/mL), we investigated several cytoad-
herence interactions involved in the development of high parasite
densities and the symptoms of malaria. We found that parasitized
CB RBCs are impaired in their binding to MVECs, monocytes,
and nonparasitized RBCs. Abnormal display of PfEMP-1 and
knobs on the surface of CB RBCs correlated with these findings
and is reminiscent of that on HbC and HbS RBCs [10,11]. IgG (at
physiological levels of 10 mg/mL) purified from the plasma of
immune Malian adults almost completely abolished the adherence
of parasitized AA and CB RBCs to MVECs. At lower doses (up to
6 mg/mL), immune IgG effected greater reductions in the
cytoadherence of parasitized CB RBCs than parasitized AA
RBCs, suggesting that HbF and maternal immune IgG work
cooperatively to impair cytoadherence in vivo.
We propose that HbF and PfEMP-1-specific IgG substantially
attenuate parasite virulence by weakening cytoadherence in vivo,
which prevents the sequestration of most parasitized RBCs at the
late ring stage (only early ring forms are observed circulating in
the bloodstream) and thus enables their removal from the
bloodstream by the spleen. Lower avidity interactions with host
cells might also mitigate the inflammatory potential of the
remaining sequestered parasites. By these mechanisms, HbF and
maternal immune IgG could produce the dramatic reductions in
parasite densities and malaria episodes observed in young infants
– consistent with the proposed cooperative effects of HbS and
acquired immunity [11,35]. This model suggests that HbF and
other hemoglobin variants might confer less protection against
malaria in low-transmission settings where humoral immunity is
not transplacentally or naturally acquired. This hypothesis is
further strengthened by reports of non-immune HbS children
with high parasitemias and severe malaria [36], and could be
more rigorously tested by studying non-immune hemoglobino-
pathic individuals who acquire malaria. Our findings indicate
that measurements of PfEMP-1-specific antibody levels are likely
to be particularly relevant and informative in studies of infant
immunity to malaria [37,38,39].
By altering PfEMP-1 display, HbF impairs cytoadherence by a
mechanism similar to that of HbC and HbS [10,11], two
hemoglobin variants for which malaria protection is well
documented [40,41,42,43,44,45]. Like HbC and HbS RBCs
[46], CB RBCs contain elevated levels of membrane-associated
hemichromes [47] and IgG (not shown). These and other shared
characteristics might interfere with the trafficking of PfEMP-1 to
the CB RBC membrane. In addition, the waning protective effects
of maternal immune IgG and HbF might be reconstituted by the
contemporaneous development of humoral immunity and expres-
sion of HbC and HbS in some African infants, which would
cooperate to extend malaria resistance into their early childhood.
Our data thus provide a rationale for testing whether hydroxyurea
and other HbF-inducing agents can be used as prophylaxis against
severe and fatal malaria in very young ‘wildtype’ children who lack
protective polymorphisms. Our findings also raise the possibility
that polymorphisms that produce unstable hemoglobin (HbC,
HbS, HbE, alpha- and beta-thalassemias, G6PD deficiency) confer
malaria resistance by a common mechanism. Cooperative
interactions between cytoadherence-inhibiting IgG (e.g., PfEMP-
1-specific IgG) and diverse hemoglobin variants suggest that
therapeutics and vaccines that disrupt PfEMP-1-mediated cytoad-
herence phenomena will reduce the morbidity and mortality of
malaria.
Supporting Information
Table S1 Relative red blood cell (RBC) invasion and develop-
ment, cytoadherence and rosetting, and PfEMP-1 expression on
parasitized AA and CB RBCs: data separated out by P. falciparum
line.
Found at: doi:10.1371/journal.pone.0014798.s001 (0.02 MB
DOCX)
Figure 4. Adherence of parasitized RBCs to MVECs in the presence of immune IgG. The numbers of parasitized AA and CB RBCs adhering
to 100 MVECs in the presence of either non-immune or immune IgG are shown. Comparisons were made in parallel using IgG at final concentrations
of either 10 mg/mL (a) or 0.5–6 mg/mL (b). Median values are indicated by horizontal bars. Results were obtained from 2 parasite lines (3D7, FCR-3),
multiple blood donors (6AA, 6CB), and 4 endothelial cell lots. For each combination of parasite line and RBC sample tested, the numbers of
parasitized RBCs bound to 100 MVECs are shown in Table S2.
doi:10.1371/journal.pone.0014798.g004
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blood cells (RBCs) to microvascular endothelial cells (MVECs) in
the presence of nonimmune IgG (NIgG) or immune IgG (IIgG).
Found at: doi:10.1371/journal.pone.0014798.s002 (0.01 MB
DOCX)
Figure S1 Morphology and distribution of knobs on the surface
of parasitized HPFH RBCs.
Found at: doi:10.1371/journal.pone.0014798.s003 (5.98 MB TIF)
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